News related to Fosamax (Alendronate) and/or conditions it is approved for
Teriparatide Outperforms Alendronate In Treating Steroid-Induced Osteoporosis
Source: Arthritis / Rheumatology News From Medical News Today [2009.10.30]
A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid-induced OP who were treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.
Better Drug Emerges for Steroid-Induced Bone Loss (HealthDay)
Source: Y! Health Bones, Joints & Muscles News [2009.10.29]
HealthDay - THURSDAY, Oct. 29 (HealthDay News) -- The drug teriparatide is
better at increasing bone density and reducing vertebral fractures in
patients with glucocorticoid-induced osteoporosis than the drug
alendronate, a new study finds.
|
